| Source: |
| Type: |
| ALDOC - Aldolase C, Fructose-Bisphosphate Type: Glycolytic enzyme / fructose-bisphosphate aldolase Function: ALDOC is a glycolytic enzyme that catalyzes the reversible conversion of fructose-1,6-bisphosphate into glyceraldehyde-3-phosphate and dihydroxyacetone phosphate. It is highly expressed in the central nervous system and contributes to glucose metabolism, cellular energy production, and metabolic adaptation. Cancer: ↕ Context-dependent. ALDOC expression is altered in multiple cancers and can influence glycolytic metabolism, proliferation, migration, and tumor progression. Increased ALDOC may support metabolic demands in some tumors, whereas reduced expression has been associated with more aggressive disease in other cancer types. |
| 7823- | ISQ, | Isoquercitrin Upregulates Aldolase C Through Nrf2 to Ameliorate OGD/R-Induced Damage in SH-SY5Y Cells |
| - | in-vitro, | Stroke, | SH-SY5Y |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1705 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid